Quarterly Results

ASTRAZENECA PHARMA INDIA LTD.

NSE : ASTRAZENBSE : 506820ISIN CODE : INE203A01020Industry : Pharmaceuticals & DrugsHouse : Astrazeneca Pharma India - MNC
BSE3038.65-13.15 (-0.43 %)
PREV CLOSE ( ) 3051.80
OPEN PRICE ( ) 3144.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 717
TODAY'S LOW / HIGH ( )3035.00 3144.95
52 WK LOW / HIGH ( )3000 4900
NSE3039.90-13.9 (-0.46 %)
PREV CLOSE( ) 3053.80
OPEN PRICE ( ) 3053.80
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 14393
TODAY'S LOW / HIGH( ) 3030.00 3089.70
52 WK LOW / HIGH ( )3005 4910
Quarters
Select year  
( in Million)
Particulars
Jun 2021
Mar 2021
Dec 2020
Sep 2020
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
1754.02
2102.57
2002.52
2094.77
Total Expenditure
1597.72
1698.48
1695.09
1737.21
PBIDT (Excl OI)
156.3
404.09
307.43
357.56
Other Income
28.99
25.53
29.28
47.13
Operating Profit
185.3
429.62
336.71
404.69
Interest
2.66
2.82
2.6
2.77
Exceptional Items
NA
NA
NA
NA
PBDT
182.64
426.8
334.11
401.92
Depreciation
47.61
58.42
51.1
46.22
Profit Before Tax
135.03
368.38
283.01
355.7
Tax
32.61
95.6
72.49
92.32
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
102.42
272.78
210.52
263.38
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
0.00
0.00
0.00
0.00
Net Profit
102.42
272.78
210.52
263.38
Equity Capital
50
50
50
50
Face Value (IN RS)
2
2
2
2
Reserves
Calculated EPS
4.09
10.91
8.42
10.53
Calculated EPS (Annualised)
16.38
43.64
33.68
42.14
No of Public Share Holdings
6250000
6250000
6250000
6250000
% of Public Share Holdings
25
25
25
25
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
8.91
19.21
15.35
17.06
PBIDTM%
10.56
20.43
16.81
19.31
PBDTM%
10.41
20.29
16.68
19.18
PBTM%
7.69
17.52
14.13
16.98
PATM%
5.83
12.97
10.51
12.57
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)